Literature DB >> 19384849

Kidney graft loss associated with JC polyomavirus nephropathy.

Davide Rolla1, Claudio G Giacomazzi, Raffaella Gentile, Jean Louis Ravetti, Giuseppe Cannella, Oliviero E Varnier.   

Abstract

This is the first case of documented treatment failure of JCV nephritis, despite a reduction of immunosuppressive agents and the use of antiviral therapy. We consistently detected high levels of JCV viremia, which correlated with the progressive deterioration of the graft and caused the final loss of the kidney, suggesting that JCV plays an etiological role in the onset of severe nephropathy in kidney transplant patients.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19384849

Source DB:  PubMed          Journal:  J Nephrol        ISSN: 1121-8428            Impact factor:   3.902


  2 in total

1.  Urinary JCV-DNA testing during natalizumab treatment may increase accuracy of PML risk stratification.

Authors:  A Laroni; C G Giacomazzi; L Grimaldi; P Gallo; M P Sormani; A Bertolotto; J L McDermott; I Gandoglia; I Martini; G Vitello; F Rinaldi; L Barzon; V Militello; M Pizzorno; F Bandini; E Capello; G Palù; A Uccelli; G L Mancardi; O E Varnier
Journal:  J Neuroimmune Pharmacol       Date:  2012-05-16       Impact factor: 4.147

2.  Decoy Cells versus Plasma Real-Time Polymerase Chain Reaction for the Detection of Polyomaviruses in Renal Transplant Patients: A Single Institutional Experience.

Authors:  Nasar Y Alwahaibi; Thuraya M Al Maskari; Najat Aldairi
Journal:  J Cytol       Date:  2019-12-23       Impact factor: 1.000

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.